Sciegen Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?
SCIEGEN PHARMS INC has one hundred and two approved drugs.
Summary for Sciegen Pharms Inc
| US Patents: | 0 |
| Tradenames: | 81 |
| Ingredients: | 80 |
| NDAs: | 102 |
Drugs and US Patents for Sciegen Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciegen Pharms Inc | CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 214092-003 | May 7, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciegen Pharms Inc | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 205236-003 | May 26, 2017 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciegen Pharms Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 203769-003 | Sep 11, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
